Progesterone receptor (PR) antagonism by telapristone acetate (TPA): A randomized, placebo-controlled phase IIB pre-surgical window trial in women with stage 0-II breast cancerO. Lee,M. E. Sullivan,Y. Xu, A. Shidfar,D. Ivancic, Z. Zeng,H. Singhal,I. Helenowski,B. Jovanovic,N. Hansen, K. Bethke,P. Gann, W. J. Gradishar, S. E. Clare,S. A. KhanCANCER RESEARCH（2019）引用 0|浏览62暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
